246 related articles for article (PubMed ID: 23741309)
1. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.
Liu L; Wang Z; Jiang S; Shao B; Liu J; Zhang S; Zhou Y; Zhou Y; Zhang Y
PLoS One; 2013; 8(5):e64261. PubMed ID: 23741309
[TBL] [Abstract][Full Text] [Related]
2. The impact of perioperative allogeneic blood transfusion on prognosis of hepatocellular carcinoma after radical hepatectomy: A systematic review and meta-analysis of cohort studies.
Xun Y; Tian H; Hu L; Yan P; Yang K; Guo T
Medicine (Baltimore); 2018 Oct; 97(43):e12911. PubMed ID: 30412094
[TBL] [Abstract][Full Text] [Related]
3. Perioperative Allogenenic Blood Transfusion is Associated With Worse Clinical Outcome for Patients Undergoing Gastric Carcinoma Surgery: A Meta-Analysis.
Li L; Zhu D; Chen X; Huang Y; Ouyang M; Zhang W
Medicine (Baltimore); 2015 Sep; 94(39):e1574. PubMed ID: 26426632
[TBL] [Abstract][Full Text] [Related]
4. Safety and advantage of perioperative autologous blood transfusion in hepatic resection for hepatocellular carcinoma.
Kitagawa K; Taniguchi H; Mugitani T; Koh T; Obayashi T; Kunishima S; Yamaguchi A; Yamagishi H
Anticancer Res; 2001; 21(5):3663-7. PubMed ID: 11848540
[TBL] [Abstract][Full Text] [Related]
5. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
[TBL] [Abstract][Full Text] [Related]
6. Impact of intraoperative vascular occlusion during liver surgery on long-term outcomes: A systematic review and meta-analysis.
Gong C; Wang H; Liu P; Guo T
Int J Surg; 2017 Aug; 44():110-116. PubMed ID: 28645555
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review.
Hung AK; Guy J
World J Gastroenterol; 2015 Nov; 21(42):12197-210. PubMed ID: 26576104
[TBL] [Abstract][Full Text] [Related]
8. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
9. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.
Yang WS; Va P; Bray F; Gao S; Gao J; Li HL; Xiang YB
PLoS One; 2011; 6(12):e27326. PubMed ID: 22205924
[TBL] [Abstract][Full Text] [Related]
10. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.
Tung-Ping Poon R; Fan ST; Wong J
Ann Surg; 2000 Jul; 232(1):10-24. PubMed ID: 10862190
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
Ni JY; Liu SS; Xu LF; Sun HL; Chen YT
World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128
[TBL] [Abstract][Full Text] [Related]
12. No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis.
Peng T; Zhao G; Wang L; Wu J; Cui H; Liang Y; Zhou R; Liu Z; Wang Q
Clin Transl Oncol; 2018 Jun; 20(6):719-728. PubMed ID: 29080121
[TBL] [Abstract][Full Text] [Related]
13. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
[TBL] [Abstract][Full Text] [Related]
14. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.
Makino Y; Yamanoi A; Kimoto T; El-Assal ON; Kohno H; Nagasue N
Am J Gastroenterol; 2000 May; 95(5):1294-300. PubMed ID: 10811342
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of laparoscopic versus open resection for hepatocellular carcinoma.
Zhou YM; Shao WY; Zhao YF; Xu DH; Li B
Dig Dis Sci; 2011 Jul; 56(7):1937-43. PubMed ID: 21259071
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma.
Xiong JJ; Altaf K; Javed MA; Huang W; Mukherjee R; Mai G; Sutton R; Liu XB; Hu WM
World J Gastroenterol; 2012 Dec; 18(45):6657-68. PubMed ID: 23236242
[TBL] [Abstract][Full Text] [Related]
17. Effect of Perioperative Transfusion on Postoperative Morbidity Following Minimally Invasive Hysterectomy for Benign Indications.
Tyan P; Taher A; Carey E; Amdur R; Messersmith C; Robinson HN; Gu A; Vargas MV; Moawad GN
J Minim Invasive Gynecol; 2020 Jan; 27(1):200-205. PubMed ID: 30930213
[TBL] [Abstract][Full Text] [Related]
18. [A meta-analysis of radiofrequency ablation for early hepatocellular carcinoma].
Huang X; Lü B; Meng LN
Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):217-20. PubMed ID: 18785506
[TBL] [Abstract][Full Text] [Related]
19. An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis.
Salhab M; Canelo R
J Cancer Res Ther; 2011; 7(4):463-75. PubMed ID: 22269411
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
